ArticleTherapeutic advances in musculoskeletal disease2012

Bazedoxifene: the evolving role of third-generation selective estrogen-receptor modulators in the management of postmenopausal osteoporosis.

Barry S Komm et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.